Latest News
Austrian Drugmaker Ever Pharma Acquires Amneal Deutschland
Friday 17 May 2019

17 May 2019 - Austrian specialty pharmaceuticals company Ever Pharma Holding Ges.m.b.H has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the company's commercial operations in Germany, the company said.

Amneal Deutschland already distributes several Ever Pharma products in Germany and is a strongly established player in the German hospital market.

The acquired entity will be rebranded to Ever Pharma GmbH.

Ever Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production and commercialisation of products in the areas of neurology, critical care, anesthesia and oncology.

Ever Pharma markets in over 70 countries through wholly owned affiliates and distribution partners.
Details
Date Published: 17/05/2019
Target: Amneal Deutschland GmbH
Country: Germany
Sector: Pharmaceuticals
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: Ever Pharma Holding Ges.m.b.H
Comment:
Terms of the deal were not disclosed

Options